Navigation Links
Volcano Announces the Introduction of the Eagle Eye® Platinum Digital IVUS Catheter at the 20th PCI Live Demonstration Course in Kurashiki
Date:3/4/2011

SAN DIEGO, March 4, 2011 /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it received clearance to market the Eagle Eye® Platinum digital IVUS catheter in Japan, and will introduce the device at the 20th PCI Live Demonstration Course in Kurashiki, which starts on March 3rd. This state-of-the-art catheter offers all of the benefits of the predecessor Eagle Eye® Gold catheter, plus improved deliverability and the convenience of additional radiopaque markers. Full market release of Eagle Eye® Platinum in Japan is expected in the second quarter of 2011.

"Volcano is thrilled to offer our most advanced digital IVUS catheter to the largest – and most developed – IVUS market in the world," commented David Sheehan, President of the IVUS and FM Business Units at Volcano Corporation. "Since the catheter's release in the US and Europe, customers have been impressed with its deliverability through tortuous anatomy and complex lesions, and have appreciated the ability to more accurately perform angiographic lesion length assessments by using the integrated radiopaque markers instead of taking the time to use a separate pullback device. We are expecting the strong interest that Japanese physicians have shown for the Eagle Eye® Platinum catheter to carry over into their clinical experience as well."

"In Japan, physicians are tackling increasingly complex and challenging PCI," added Junichi Osawa, President and Managing Director of Volcano Japan. "The more tapered tip design of the Eagle Eye Platinum catheter, with lower entry profile and new GlyDx® hydrophilic coating, facilitates guidance of CTO procedures, and the smoother lower profile catheter transitions improve delivery through smaller guides. This can help facilitate radial access, an approach common in Japan and growing elsewhere in the world due to reduced bleeding complications."

About Eagle Eye® Platinum

The Eagle Eye® Platinum is the third generation of catheters in the Eagle Eye® product line. Eagle Eye® catheters have been used in over 500,000 procedures worldwide. Like Eagle Eye® Gold, the Eagle Eye® Platinum catheter offers fast, plug-and-play functionality as well as grayscale IVUS, VH® IVUS, and ChromaFlo® imaging modalities.

About Volcano Corporation

Volcano Corporation (NASDAQ: VOLC) is revolutionizing the medical device industry with a broad suite of technologies that make imaging and therapy simpler, more informative and less invasive. Our products empower physicians around the world with a new generation of analytical tools that deliver more meaningful information, using sound and light as the guiding elements.  Founded in cardiovascular care and expanding into other specialties, Volcano is changing the assumption about what is possible in improving patient outcomes by combining imaging and therapy together.  For more information, visit the company's website at www.volcanocorp.com.

Forward-Looking Statements  

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this release that are not historical facts may be considered "forward-looking statements." Forward-looking statements are based on management's current preliminary expectations and are subject to risks and uncertainties which may cause Volcano's results to differ materially and adversely from the statements contained herein. Some of the potential risks and uncertainties that could cause actual results to differ from those predicted include competition, the pace and extent of market adoption of the Eagle Eye® Platinum in Japan, unexpected new data, safety and technical issues,, and market conditions.  These and additional risks and uncertainties are more fully described in Volcano's filings made with the Securities and Exchange Commission. Undue reliance should not be placed on forward-looking statements which speak only as of the date they are made. Volcano disclaims any obligation to update any forward-looking statements to reflect new information, events or circumstances after the date they are made, or to reflect the occurrence of unanticipated events.


'/>"/>
SOURCE Volcano Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Volcano Presentation at Thomas Weisel Conference to Be Webcast
2. Volcano Corporation Announces Launch of PrimeWire(TM) Pressure Guidewire and s5-FFR Option for Existing Fleet of s5 IVUS Consoles
3. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
4. Volcano Corporation Presentation at J.P. Morgan Conference to be Webcast
5. Volcano Announces Closing of Axsun Technologies Acquisition
6. Volcano Corporation Presentation at Roth Capital Partners Conference to Be Webcast
7. Volcano Corporation Schedules First Quarter Conference Call, Webcast
8. Volcano Corporation Presentation At Canaccord Adams Conference To Be Webcast
9. Volcano Corporation Announces Schedule of Events for the 2009 Transcatheter Cardiovascular Therapeutics (TCT) Conference
10. Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
11. Volcano Corporation Presentation at Roth Capital Partners Conference to be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... 10, 2016  Matchbook, Inc., a company specializing ... biotech companies, announced today the appointment of ... Jim brings nearly 25 years of experience in ... spent nearly two decades in executive level roles ... at Genzyme and, most recently headed global logistics ...
(Date:2/10/2016)... ... February 10, 2016 , ... SonaCare Medical, LLC ... support program, Sonalink™ remote monitoring. The inaugural launch of this new technology occurred ... connecting Dr. Samuel Peretsman to a HIFU technical expert at SonaCare Medical headquarters. ...
(Date:2/10/2016)... ... February 10, 2016 , ... Cenna Bioscience Inc., an emerging biopharmaceutical company focused ... announced today it has been selected to present at the Cavendish Global Health Impact ... Florida. The purpose of the Forum is to help family offices and foundations ...
(Date:2/9/2016)... ... ... Date and time: March 1, 2016, 5:30 p.m. to ... of Bucks County, 3805 Old Easton Road, Doylestown, PA 18902. , The Baruch ... house for participants to learn about a new Master of Biomedical Science (MBS) ...
Breaking Biology Technology:
(Date:1/25/2016)... , Jan. 25, 2016  Glencoe Software, the ... pharma and publication industries, will provide the data management ... Centre (NPSC). ... Phenotypic analysis measures ... whole organisms, allowing comparisons between states such as health ...
(Date:1/21/2016)... India , January 21, 2016 ... According to a new market research report "Emotion Detection ... and Others), Software Tools (Facial Expression, Voice Recognition ... Regions - Global forecast to 2020", published by ... is expected to reach USD 22.65 Billion by ...
(Date:1/20/2016)... Calif. , Jan. 20, 2016  Synaptics ... of human interface solutions, today announced sampling of ... solution for wearables and small screen applications including ... as printers. Supporting round and rectangular shapes, as ... offers excellent performance with moisture on screen, while ...
Breaking Biology News(10 mins):